In light of the COVID-19 pandemic, the U.S. Food and Drug Administration (FDA) has announced several steps to maintain the safe supply of food while adjusting the regulatory burden on food manufacturers. The FDA also announced that there is no evidence of transmission of the virus via food or packaging and stated that food manufacturers
FDA
FDA Issues Warning Letters Regarding Adulterated Cosmetics
By Tommy Tobin & Jason Howell on
Posted in Claim Substantiation
In September 2019, the FDA sent warning letters to three tattoo ink manufacturers about microbial contamination in the products. The agency conducted microbial analysis of tattoo ink samples collected from customers around the country.
The warning letters noted that the tattoo inks contained pathogens and microorganisms that rendered them adulterated under the Federal Food Drug & Cosmetic Act (FFDCA). The agency regulates tattoo inks as “cosmetics” under the FFDCA because the inks are introduced into the body to “promot[e] attractiveness” or “alter[] the appearance.” See 21 U.S.C. § 321(i).
Continue Reading FDA Issues Warning Letters Regarding Adulterated Cosmetics
A Cosmetic, A Drug, or Both?
By Tommy Tobin on
Posted in False Advertising
Takeaways:
- The intended uses of products are relevant to their classification as a cosmetic and/or a drug.
- Products can be regulated concurrently as both a drug and a cosmetic depending on intended uses.
- Companies should be aware of claims of intended uses of products to ensure these products are properly classified under federal law.
Talc, Asbestos, and FDA Regulation of Cosmetics
By Tommy Tobin on
Posted in Class Actions
Takeaways:
- Recent detection of cosmetic products containing asbestos has led to voluntary recalls of five products so far this year.
- At present, the FDA does not have mandatory recall authority over cosmetic products.
- The FDA and Congress are contemplating proposals concerning the cosmetics industry that may lead to further enforcement activity in this sector.
…
Continue Reading Talc, Asbestos, and FDA Regulation of Cosmetics